Fenfluramine for Lennox-Gastaut Syndrome: Long-Term Efficacy

disease deep dive

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Rethinking Multiple Sclerosis: A New Biologic Framework for MS Progression
Rethinking Multiple Sclerosis: A New Biologic Framework for MS Progression
MS & Immune Disorders
Rethinking Multiple Sclerosis: A New Biologic Framework for MS Progression
Daniel Ontaneda, MD, PhD
Daniel Ontaneda, MD, PhD
Tavapadon Treatment for Early Parkinson Disease: Findings from the TEMPO Trials
Tavapadon Treatment for Early Parkinson Disease: Findings from the TEMPO Trials
Movement Disorders
Tavapadon Treatment for Early Parkinson Disease: Findings from the TEMPO Trials
Hubert Fernandez, MD
Hubert Fernandez, MD
Could a Novel Oral Therapy Change How Clinicians Treat Obstructive Sleep Apnea? Insights From the SynAIRgy Trial
Could a Novel Oral Therapy Change How Clinicians Treat Obstructive Sleep Apnea? Insights From the SynAIRgy Trial
Sleep
Could a Novel Oral Therapy Change How Clinicians Treat Obstructive Sleep Apnea? Insights From the SynAIRgy Trial
Patrick J. Strollo Jr, MD, FACP, FCCP, FAASM
Patrick J. Strollo Jr, MD, FACP, FCCP, FAASM
Early Alzheimer Disease Detection with the DAC-SP Blueprint Program: Overview of a Scalable Health System Approach
Early Alzheimer Disease Detection with the DAC-SP Blueprint Program: Overview of a Scalable Health System Approach
Alzheimer Disease & Dementias
Early Alzheimer Disease Detection with the DAC-SP Blueprint Program: Overview of a Scalable Health System Approach
Elyse Perweiler, RN, MPP; Tim MacLeod, PhD
Elyse Perweiler, RN, MPP; Tim MacLeod, PhD